Shionogi Limited
FDA Approves Xofluza for Influenza
Xofluza is indicated for the treatment of acute uncomplicated influenza in patients aged 12 years and older who ...
OCTOBER 24, 2018
FDA Approves Mulpleta for Thrombocytopenia in Adults With Chronic Liver Disease
The FDA approved lusutrombopag for thrombocytopenia in adults with chronic liver disease who are scheduled to ...
JULY 31, 2018
Janssen, ViiV Healthcare Collaborate on HIV Regimen Study
A two-drug combination of cabotegravir and rilpivirine is being studied for HIV.
JANUARY 19, 2016
Load more